OpenVSafe by OpenVAERS
Search V-safe

RQ6-26538-57372

3 vaccinations 4 coded responses 12 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
082 / NJ
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Conjunctival haemorrhage — Feeling: Good · Site: Pain
    Free text: subconjunctival hemorrhage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Conjunctival haemorrhage — Feeling: Good
    Free text: subconjunctival hemorrhage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-29
    Survey response — day 7, dose 1
    MedDRA: Conjunctival haemorrhage — Feeling: Good
    Free text: Subconjunctival hemorrhage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  7. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-11-02
    Dose 3 — Pfizer-BioNTech
  16. 2022-01-12
    Survey response — 12 months, dose 2
    MedDRA: Aphonia, Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cough, congestion, loss of voice.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-12
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-01-14
  19. 2022-01-20

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-11-02Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-27

Systemic reaction (other): subconjunctival hemorrhage

2020-12-28

Systemic reaction (other): subconjunctival hemorrhage

Release 1 — day 7, dose 1

2020-12-29

Systemic reaction (other): Subconjunctival hemorrhage

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: Cough, congestion, loss of voice.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAphonia · · ✓
SDCough · · ✓
SDRespiratory tract congestion · · ✓
SROConjunctival haemorrhage ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…